Listing Id: 28170
Last Refreshed: 29/04/2023
Total Views: 978
(On Hold)Passive Income Retire By Christmas
GeylangMedical SupplyBiomedical Manufacturers
Asking Price: Under S$50K
Business For Takeover
Look For Investor
Look For Partner
- Overview
- Reason For Sale
- Description
Overview
-
Premise Type
Work at Home
-
Premise Size
N/A
-
Monthly Rental
N/A
-
Rental Desposit
N/A
-
Revenue
N/A
-
Liability
N/A
-
Gross Profit
N/A
-
Net Profit
N/A
-
Stock
N/A
-
FFE
N/A
-
Payable
N/A
-
Receivable
N/A
-
Owner Role
Investor
-
Staff
N/A
-
Established
N/A
-
Source
Direct Seller
Reason For Sale
Investment required for expansion
Description
Once in a lifetime opportunity to invest early in one of the most exciting pharmaceutical companies offering the greatest medical breakthrough of the twenty first century.
Our Australian Company has spent years developing our product and we are now ready to mass market to the world.
Our product release announcement will make news headlines around the world. Projected sales in the USA are expected to exceed $30 million per month by the end of the year.
To help fund the growth of our company at this critical stage, we are offering the sale of up to 10% shareholding in our Company. Shareholders will Own part of the company and receive monthly dividends based on sales.
Minimum investment starts at $5,000
For more information about our company and our world leading product, please request our business brief.